title: [Use of gold radionuclide markers implanted into the prostate for image-guided radiotherapy in prostate cancer: side effects caused by the marker implantation].
abstract: The purpose of the study was to introduce the use of the gold radiopaque markers implanted into the prostate for image-guided radiotherapy of prostate cancer patients and to present the side effects caused by the marker implantation. Between November 2011 and November 2013, three radiopaque, gold-plated markers (Best Medical International, Springfield, VA, USA, 1.0 mm x 3.0 mm) were implanted transperineally into the prostate of 60 patients under transrectal ultrasound guidance. Local anaesthesia was performed in all patients. A week after the procedure the patients filled in a questionnaire regarding the pain, dysuria, urinary frequency, nycturia, rectal bleeding, haematuria, haematospermia or fever symptoms caused by the implantation. The pain caused by the intervention was scored on a 1-10 scale, where 1 was a very weak and 10 was an unbearable pain. Ten days after the implantation a treatment planning CT was performed and subsequently patients started intensity-modulated radiation therapy (IMRT) within one week. During the treatments markers were used for daily verification and correction of patient's setup. No patients experienced fever or infection. Based on the questionnaires nobody experienced dysuria or rectal bleeding after implantation. Among the 60 patients studied, five (8 %) had haematospermia, nine (15 %) haematuria, which lasted in average of 3.4 and 1.8 days, respectively. The average pain score on 1-10 scale was 4.2 (range: 0-9). After the marker implantation 18 patients (30%) reported less, 10 patients (17%) more, and 27 patients (45%) equal amount of pain compared to biopsy. Five patients, who had a biopsy performed under general anaesthesia, did not answer this question. None of the patients needed analgesics after implantation. The gold marker implantation implemented for image-guided radiotherapy was well tolerated under a local anaesthesia. The complications were limited, rate and frequency of perioperative pain was comparable to the pain caused by biopsy. After implantation, the patients did not require analgesics. The method can be performed safely in clinical practice.
authors.affiliation: Sugárterápiás Központ, Országos Onkológiai Intézet, Budapest, Hungary. jorgokliton@gmail.com.
authors.forename: Jorgo
authors.initials: J
authors.lastname: Kliton
authors.affiliation: Sugárterápiás Központ, Országos Onkológiai Intézet, Budapest, Hungary. jorgokliton@gmail.com.
authors.forename: Péter
authors.initials: P
authors.lastname: Ágoston
authors.affiliation: Sugárterápiás Központ, Országos Onkológiai Intézet, Budapest, Hungary. jorgokliton@gmail.com.
authors.forename: Zoltán
authors.initials: Z
authors.lastname: Szabó
authors.affiliation: Sugárterápiás Központ, Országos Onkológiai Intézet, Budapest, Hungary. jorgokliton@gmail.com.
authors.forename: Tibor
authors.initials: T
authors.lastname: Major
authors.affiliation: Sugárterápiás Központ, Országos Onkológiai Intézet, Budapest, Hungary. jorgokliton@gmail.com.
authors.forename: Csaba
authors.initials: C
authors.lastname: Polgár
mesh_terms: D000368:Aged; D001707:Biopsy, Needle; D005334:Fever / Q000209:etiology; D006050:Gold Radioisotopes / Q000009:adverse effects*; D006417:Hematuria / Q000209:etiology; D051516:Hemospermia / Q000209:etiology; D006801:Humans; D006814:Hungary; D007249:Inflammation / Q000209:etiology; D008297:Male; D010146:Pain / Q000209:etiology; D011446:Prospective Studies; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D019736:Prostheses and Implants; D061089:Radiotherapy, Image-Guided / Q000009:adverse effects* / Q000379:methods*; D050397:Radiotherapy, Intensity-Modulated / Q000009:adverse effects* / Q000379:methods*; D011795:Surveys and Questionnaires
chemical_list: D006050:Gold Radioisotopes